EyePoint Pharmaceuticals Inc (EYPT)
11.66
-0.40
(-3.32%)
USD |
NASDAQ |
Nov 04, 13:01
EyePoint Pharmaceuticals Profit Margin (Quarterly): -325.3% for June 30, 2024
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2024 | -325.3% |
| March 31, 2024 | -250.6% |
| December 31, 2023 | -100.5% |
| September 30, 2023 | -82.96% |
| June 30, 2023 | -251.7% |
| March 31, 2023 | -275.5% |
| December 31, 2022 | -412.5% |
| September 30, 2022 | -184.0% |
| June 30, 2022 | -167.8% |
| March 31, 2022 | -225.7% |
| December 31, 2021 | -168.3% |
| September 30, 2021 | -184.3% |
| June 30, 2021 | -111.1% |
| March 31, 2021 | -167.7% |
| December 31, 2020 | -216.9% |
| September 30, 2020 | -24.22% |
| June 30, 2020 | -314.2% |
| March 31, 2020 | -175.9% |
| December 31, 2019 | -120.6% |
| September 30, 2019 | -623.6% |
| June 30, 2019 | -159.5% |
| March 31, 2019 | -956.2% |
| September 30, 2018 | -6.82K% |
| June 30, 2018 | -4.82K% |
| March 31, 2018 | -751.9% |
| Date | Value |
|---|---|
| December 31, 2017 | -619.7% |
| September 30, 2017 | -1.55K% |
| June 30, 2017 | -872.5% |
| March 31, 2017 | -871.2% |
| December 31, 2016 | -1.12% |
| September 30, 2016 | -2.59K% |
| June 30, 2016 | -2.10K% |
| March 31, 2016 | -1.56K% |
| December 31, 2015 | -985.9% |
| September 30, 2015 | -1.06K% |
| June 30, 2015 | -1.26K% |
| March 31, 2015 | -1.52K% |
| December 31, 2014 | -782.1% |
| September 30, 2014 | 81.27% |
| June 30, 2014 | -1.36K% |
| March 31, 2014 | -109.8% |
| December 31, 2013 | -593.6% |
| September 30, 2013 | -617.6% |
| June 30, 2013 | -802.2% |
| March 31, 2013 | -544.6% |
| December 31, 2012 | -445.8% |
| September 30, 2012 | -461.3% |
| June 30, 2012 | -323.6% |
| March 31, 2012 | -499.3% |
| December 31, 2011 | -2.77K% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-412.5%
Minimum
Dec 2022
-24.22%
Maximum
Sep 2020
-197.9%
Average
-184.0%
Median
Sep 2022
Profit Margin (Quarterly) Benchmarks
| Cassava Sciences Inc | -- |
| Adverum Biotechnologies Inc | -- |
| Regenxbio Inc | -237.7% |
| Editas Medicine Inc | -13.18K% |
| Apellis Pharmaceuticals Inc | -18.86% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | -50.45% |
| Return on Assets | -32.29% |
| Return on Invested Capital | -50.45% |
| Gross Profit Margin (Quarterly) | 85.22% |
| Operating Margin (Quarterly) | -364.5% |
| Return on Net Operating Assets | -327.8% |